Aptose Biosciences Inc (TSX:APS) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Caroline M Loewy Other companies: eFFECTOR Therapeutics Inc (Director · Sep 9, 2023 – Jun 13, 2024 · Past); CERo Therapeutics Holdings, Inc. (Director · Oct 5, 2021 – Feb 14, 2024 · Past); Zogenix Inc (Director · Sep 21, 2020 – Mar 7, 2022 · Past); PhaseBio Pharmaceuticals Inc (Director · Oct 17, 2018 – May 19, 2023 · Past) | Director · Dec 21, 2018 – Jan 18, 2022 · Past |
| Bernd R. Seizinger Other companies: Oncolytics Biotech Inc. (Director · Since at least Jan 1, 2026); Aprea Therapeutics, Inc. (Director · Since at least Oct 2, 2019) | Director · Sep 13, 2022 – Feb 5, 2024 · Past |
| Denis R Burger Other companies: CytoDyn Inc. (Director · Feb 7, 2014 – Jul 12, 2018 · Past); Sarepta Therapeutics, Inc. (Chief Executive Officer, Director · Feb 16, 2006 – Apr 3, 2007 · Past) | Director · Dec 21, 2018 – Feb 5, 2024 · Past |
| Jotin Marango Other companies: ImageneBio, Inc. (Chief Financial Officer · Since at least Apr 25, 2022) | Senior VP, CFO, and CBO · Jun 3, 2019 – Jan 18, 2022 · Past |
| Brian Underdown | Until Jan 20, 2015 · Past |
| Erich Platzer | Director · Dec 15, 2014 – Feb 5, 2024 · Past |
| Philippe Ledru | Sr VP & Ch Commerical Officer · Feb 5, 2024 – Feb 5, 2024 · Past |
| Rafael Bejar | Sr VP & Chief Medical Officer · Jan 4, 2021 – Feb 5, 2024 · Past |
| Warren Whitehead | Director · Dec 21, 2018 – Feb 5, 2024 · Past |
| William G Rice | Chair, President & CEO, Director · Since at least Jan 4, 2021 |